BRAINLIFE Brain Tumor Medical Database

Cisplatin

Home > Database > Treatment > Cisplatin (CDDP)

Contents


Astrocytomas


Mathieu NT, Genet D, Labrousse F, Bouillet P, Denes SL, Martin J, Labourey JL, Venat L, Clavere P, Moreau JJ
Pre-irradiation chemotherapy for newly diagnosed high grade astrocytoma
Anticancer Res. 2004 Mar-Apr;24(2C):1249-53.


Embryonal Tumors


H. Shirato, J. Ikeda, H. Aoyama, N. Ishii, T. Taguchi, T. Kato, M. Tada, Y. Sawamura
Low-dose craniospinal irradiation and ifosfamide, cisplatine, and etoposide for embryonal tumors in central nervous system
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 430 


Germ Cell Tumors


Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol
J Clin Oncol. 2004 Mar 1;22(5):846-53.


Glioblastoma


Carmen Balaña, Antonio López-pousa, Alfonso Berrocal, Ricardo Yaya-tur, Ana Herrero, Jose-luis García, Javier Martín-broto, Manuel Benavides, Miguel Cerdá-nicolás, Rosa Ballester, Josep Balart, Jaume Capellades
Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)
Journal of Neuro-Oncology, 70(3): 359-370, December 2004. (Abstract+)

Balana C, Ramirez JL, Taron M, Roussos Y, Ariza A, Ballester R, Sarries C, Mendez P, Sanchez JJ, Rosell R
O(6)-methyl-guanine-DNA methyltransferase Methylation in Serum and Tumor DNA Predicts Response to 1,3-Bis(2-Chloroethyl)-1-Nitrosourea but not to Temozolamide Plus Cisplatin in Glioblastoma Multiforme
Clin Cancer Res 2003 Apr;9(4):1461-8

Radiotherapy, Cisplatin, Fotemustine, Temozolomide (Recurrent). 
Radiotherapy, Temozolomide (First-diagnosis)

Balducci M, Chiesa S, Diletto B, D'Agostino GR, Mangiola A, Manfrida S, Mantini G, Albanese A, Fiorentino A, Frascino V, De Bari B, Micciche' F, De Rose F, Morganti AG, Anile C, Valentini V.
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.
Neuro Oncol. 2011 Oct 12;. [Epub ahead of print]
  Abstract |   Related articles

Alba A. Brandes, Umberto Basso, Michele Reni, Francesca Vastola, Alicia Tosoni, Giovanna Cavallo, Luciano Scopece, Andres J. Ferreri, Maria G. Panucci, Silvio Monfardini, Mario Ermani
First-Line Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma Multiforme: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia
Journal of Clinical Oncology, Vol 22, No 9 (May 1), 2004: pp. 1598-1604.

In Sil Choi , Se Hoon Lee, Tae-You Kim, Sun Ha Paek, Suzy Kim, Il Han Kim, Dae Seog Heo,Yung-Jue Bang, Dong Gyu Kim, Hee-Won Jung, Noe Kyeong Kim
Phase II Study of Chemotherapy with ACNU Plus Cisplatin Followed by Cranial Irradiation in Patients with Newly Diagnosed Glioblastoma Multiforme
Journal of Neuro-Oncology
, 60 (2): 171-176, November 2002

C. F. Classen, M. Warmuth-Metz, K. Papke, A. Trotter, J. E. A. Wolff, S. Wagner
Late response to radiochemotherapy in pediatric glioblastoma: report on two patients treated according to HIT-GBM protocols
Pediatr Hematol Oncol. 2006 Dec;23(8):631-7. DOI: 10.1080/08880010600951088

Mario Ermani, Alba A Brandes, Lara M Pasetto, Umberto Basso, Michele Reni, Sergio Turazzi, Silvia Berlucchi, Paolo Iuzzolino, Giampietro Pinna, Renato Scienza, Silvio Monfardini
First line chemotherapy with cisplatin plus fractionated temozolomide (bid) in recurrent glioblastoma (GBM)
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.  

E. Franceschi, L. Scopece, G. Cavallo, R. Degli Esposti, F. Spagnolli, S. Rimondini, R. Conforti, E. Palmerini, S. Gori, L. Crino
Temozolomide and cisplatin for the treatment of glioblastoma: A phase II study
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 481  

Han JH, Park CK, Lee SH, Kim CY, Kim DW, Paek SH, Kim DG, Heo DS, Kim IH, Jung HW.
Preradiation Chemotherapy with ACNU-CDDP in Patients with Newly Diagnosed Glioblastoma: A Retrospective Analysis
Chemotherapy. 2009 Apr 22;55(3):145-154. [Epub ahead of print]
  Abstract

Kim IH, Park CK, Heo DS, Kim CY, Rhee CH, Nam DH, Lee SH, Han JH, Lee SH, Kim TM, Kim DW, Kim JE, Paek SH, Kim DG, Kim IA, Kim YJ, Kim JH, Park BJ, Jung HW.
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.
J Neurooncol. 2010 Nov 4. [Epub ahead of print]
  Abstract |   Reprint |   Related articles

Sheleg SV, Korotkevich EA, Zhavrid EA, Muravskaya GV, Smeyanovich AF, Shanko YG, Yurkshtovich TL, Bychkovsky PB, Belyaev SA
Local chemotherapy with cisplatin-depot for glioblastoma multiforme

J Neurooncol 2002 Oct;60(1):53-9

E. Schuller, R. Seidl, C. Wandl, K. Dieckmann, I. Slavc
Prolonged Second Response To Cisplatin, Etoposide, And Ifosfamide In A Child With A Recurrent Brainstem Glioblastoma
Pediatric Hematology and Oncology, Volume 18, Number 4/June 1, 2001, 253 - 258
 Abstract

Silvani A, Gaviani P, Lamperti EA, Eoli M, Falcone C, Dimeco F, Milanesi IM, Erbetta A, Boiardi A, Fariselli L, Salmaggi A
Cisplatinum and BCNU chemotherapy in primary glioblastoma patients
J Neurooncol. 2009 Feb 11. [Epub ahead of print]
  Abstract


Gliomas


W. O. Arafat, D. Rein, D. Buchsbaum, D. Curiel, Z. Zhu
Survivin as a novel radiation/CIS platinum/tumor specific promoter for conditional oncolytic viral therapy
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1535 

Marco Balzarotti, Emilio Ciusani, Chiara Calatozzolo, Danilo Croci, Amerigo Boiardi, and Andrea Salmaggi
Effect of Association of Temozolomide With Other Chemotherapic Agents on Cell Growth Inhibition in Glioma Cell Lines
Oncology Research, 2004, Volume 14, pp. 325-330. 

Christine Billecke, Susan Finniss, Laura Tahash, Cathie Miller, Tom Mikkelsen, Nicholas P. Farrell and Oliver Bögler
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma
Neuro-oncol 2006 Jul 1; 8(3):215-226; Epub 2006 May 24
Abstract

Bourg V, Lebrun C, Chichmanian RM, Thomas P, Frenay M
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity.
Ann Oncol 2001 Feb;12(2):217-9
  Abstract |   Reprint |   Related articles

Maria Gonzalez Cao, Javier Aristu, Marta Santisteban, Jose M Ordonez, Jose M Aramendia, Ignacio Bilbao, Oscar Fernandez, Salvador Martin Algarra
Phase II trial of BCNU, temozolamide (TMZ) plus intraarterial cisplatin (CDDP) in unresectable or recurrent high grade glioma
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No. 2099 

Antonio Silvani,  Marica Eoli, Andrea Salmaggi, Elena Lamperti, Elio Maccagnano, Giovanni Broggi, Amerigo Boiardi
Phase II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive Malignant Glioma Patients
Journal of Neuro-Oncology, 66 (1-2): 203-208, January 2004


Gliomas (High-Grade)


Blumenthal DT, Rankin C, Eyre HJ, Livingston RB, Spence AM, Stelzer KJ, Rushing EJ, Berger MS, Rivkin SE, Cohn AL, Petersdorf SH.
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial
Cancer. 2008 Jun 2. [Epub ahead of print]
 Abstract

Dufour C, Grill J, Lellouch-Tubiana A, Puget S, Chastagner P, Frappaz D, Doz F, Pichon F, Plantaz D, Gentet JC, Raquin MA, Kalifa C.
High-grade glioma in children under 5 years of age: A chemotherapy only approach with the BBSFOP protocol.
Eur J Cancer. 2006 Sep 6; [Epub ahead of print]
Abstract

Zustovich F, Lombardi G, Della Puppa A, Rotilio A, Scienza R, Pastorelli D
A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma
Anticancer Res. 2009 Oct;29(10):4275-9
  Abstract


Gliomas (Low-Grade)


Massimino M, Spreafico F, Riva D, Biassoni V, Poggi G, Solero C, Gandola L, Genitori L, Modena P, Simonetti F, Potepan P, Casanova M, Meazza C, Clerici CA, Catania S, Sardi I, Giangaspero F
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma
J Neurooncol. 2010 Feb 12. [Epub ahead of print]
  Abstract |   Full Text |   Reprint


Medulloblastoma


Khoshyomn S, Manske GC, Lew SM, Wald SL, Penar PL
Synergistic action of genistein and cisplatin on growth inhibition and cytotoxicity of human medulloblastoma cells
Pediatr Neurosurg 2000 Sep;33(3):123-31 

Mothaffar F Rimawi, Suleiman Massarweh, Vu Ho, Uday Popat, Garrett R Lynch
Adult cerebellar medulloblastoma at Ben Taub General Hospital
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No. 2110  

Paulino AC, Mazloom A, Teh BS, South M, Okcu MF, Su J, Butler EB, Chintagumpala M
Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma
Cancer. 2010 Sep 15. [Epub ahead of print]
  Abstract |   Related articles

Saito R, Kumabe T, Sonoda Y, Kanamori M, Yamashita Y, Watanabe M, Tominaga T.
Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma.
Childs Nerv Syst. 2011 May 18. [Epub ahead of print]
  Abstract |   Related articles

Silvani A, Gaviani P, Lamperti E, Botturi A, Dimeco F, Franzini A, Ferroli P, Fariselli L, Milanesi I, Erbetta A, Pollo B, Salmaggi A.
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience.
J Neurooncol. 2011 Aug 27. [Epub ahead of print]
  Abstract |   Related articles


Metastatic Tumors


Christos Christodoulou, Dimitrios Bafaloukos, Helen Linardou, Gerassimos Aravantinos, Aristotelis Bamias, Maria Carina, George Klouvas and Dimosthenis Skarlos
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study
Journal of Neuro-Oncology, 71(1): 61-65, January 2005. (Abstract+)

Nasopharyngeal Carcinoma


G. Brandon Gunn, Ruben D. Villa, Ross R. Sedler, Fred Hardwicke, Gianluigi A. Fornari, Rufus J. Mark
Nasopharyngeal Carcinoma Metastasis to the Pituitary Gland: A Case Report and Literature Review
Journal of Neuro-Oncology, 68 (1): 87-90, May 2004. (Abstract+)

Lung Cancer


D. Y. Kim, K. W. Lee, T. Yun, J. H. Kim, D. W. Kim, S. A. Im, T. Y. Kim, D. S. Heo, Y. J. Bang, N. K. Kim
Efficacy of platinum-based chemotherapy after cranial irradiation in patients with brain metastasis from non-small cell lung cancer
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1575 

Jane W. Marsh, Maryann Donovan, Dennis R. Burholt, Lisa D. George and Paul L. Kornblith
Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents
Journal of Neuro-Oncology 66: 81–90, January 2004. (Abstract+)


Neuroblastoma


Elisabetta Donzelli, Maria Carfì, Mariarosaria Miloso, Alberto Strada, Stefania Galbiati, Martine Bayssas, Genevieve Griffon-Etienne, Guido Cavaletti, Maria Grazia Petruccioli and Giovanni Tredici
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y
J Neurooncol. 2004 Mar-Apr;67(1-2):65-73. (Abstract+)

Tsuchida R, Das B, Yeger H, Koren G, Shibuya M, Thorner PS, Baruchel S, Malkin D.
Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling
Oncogene. 2008 Jun 26;27(28):3923-34. Epub 2008 Mar 10
 Abstract


Non-Nervous System T.


Kosty MP, Fleishman SB, Herndon JE 2nd, Coughlin K, Kornblith AB, Scalzo A, Morris JC, Mortimer J, Green MR
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B
J Clin Oncol 1994 Jun;12(6):1113-20

Li D, Williams JI, Pietras RJ
Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression
Oncogene 2002 Apr 25;21(18):2805-14 

Scambia G, De Vincenzo R, Ranelletti FO, Panici PB, Ferrandina G, D'Agostino G, Fattorossi A, Bombardelli E, 
Mancuso S
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin
Eur J Cancer. 1996 May;32A(5):877-82  

Bokemeyer C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H, Lentzen H
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity
Br J Cancer. 1996 Dec;74(12):2036-41
 

Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L
Neuroprotective effect of vitamin e supplementation in patients treated with Cisplatin chemotherapy
J Clin Oncol 2003 Mar 1;21(5):927-31


Oligoastrocytoma (Anapl.)


Boiardi A, Eoli M, Salmaggi A, Pollo B, Milanesi I, Broggi G, Silvani A
Cisplatin and BCNU chemotherapy for anaplastic oligoastrocytomas
J Neurooncol 2000 Aug;49(1):71-5


Pediatric Patients


Birgit Geoerger, Gilles Vassal, Francois Doz, Marie A Raquin, Didier Frappaz, Pascal Chastagner, Herve Rubie, Jean-Claude Gentet, John O'Quigley, Kamal Djazouli, Geoffrey P Margison, Francois Pein
Dose-finding study and O6-alkyltransferase depletion of cisplatin combined with temozolomide in pediatric solid malignancies

ASCO Proceedings, 2002 Annual Meeting, Abstract No. 424 

Maura Massimino, Lorenza Gandola, Roberto Luksch, Filippo Spreafico, Daria Riva, Carlo Solero, Felice Giangaspero, Franco Locatelli, Marta Podda, Fabio Bozzi, Emanuele Pignoli, Paola Collini, Graziella Cefalo, Marco Zecca, Michela Casanova, Andrea Ferrari, Monica Terenziani, Cristina Meazza, Daniela Polastri, Davide Scaramuzza, Fernando Ravagnani, and Franca Fossati-Bellani
Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma
Neuro-Oncology, Volume 7, Number 1, Pages 41 -- 48, January 2005. (Abstract+)

 

This website is certified by Health On the Net Foundation. Click to verify. HOME ARCHIVES OF NEURO-ONCOLOGY CURRENT NEURO-ONCOLOGY NEWS CLINICAL NEURO-ONCOLOGY LIBRARY
DATABASE: Classification | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Management | Prognosis | Psychosocial Aspects | Stem Cells | Treatment
SERVICES
: About BrainLife | Children's Corner | E-mail Alerts | Journals | Links |
Motto, Dedication, etc. | Patients & Caregivers | Privacy Policy | Search | SiteMap bottom
This site complies with the HONcode standard for trustworthy health information: verify here